Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The nanomaterials can enhance the therapeutic effect of the bacterial carriers, while the bacterial carriers can enhance the therapeutic effect of the nanomaterials, thus maximizing the synergistic therapeutic effect
REG1A is associated with cell regeneration (64)
Bell et al., Nature, 304, 368 (1983) SKU(s): GLUC-008A, GLUC-008B KEYWORDS: hormone
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
US$ 24.03
US$ 24.46
US$ 25.57
US$ 28.68
